Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study.

Details

Language :

English

ISSN :

20565933

Volume :

6

Database :

Complementary Index

Journal :

RMD Open

Publication Type :

Academic Journal

Accession number :

141125751

Full Text :

https://doi.org/10.1136/rmdopen-2019-000991